5 Results for "

stat4 inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "stat4 inhibitor" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-173236
Target:  

STAT

STAT4-IN-1 is an inhibitor of STAT4 with a Ki of 0.35 μM. STAT4-IN-1 is expected to be used in the research of autoimmune diseases, including inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and diabetes .
loading...
    loading...
Cat. No.: HY-109854A
CAS No.: 100324-81-0
Purity:  99.99%
Synonyms: (R)-Lisophylline
Target:  

STAT

(R)-Lisofylline ((R)-Lisophylline) is a (R)-enantiomer of the metabolite of Pentoxifylline with anti-inflammatory properties. (R)-Lisofylline is a lysophosphatidic acid acyltransferase inhibitor with an IC50 of 0.6 μM and interrupts IL-12 signaling-mediated STAT4 activation. (R)-Lisofylline has the potential for type 1 diabetes, autoimmune disorders research .
loading...
    loading...
Cat. No.: HY-161464
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Chlopynostat (Compound 6c) is a HDAC1 inhibitor with a IC50 value of 67 nM. Chlopynostat reverses STAT4/p66Shc defects by inhibiting HDAC1-induced < b>Apoptosis .
loading...
    loading...
Cat. No.: HY-184833
CAS No.: 2417137-50-7
Target:  

JAK STAT

Tyk2-IN-25 is a TYK2 inhibitor that binds to the JH2 domain of TYK2. Tyk2-IN-25 inhibits p-STAT4 and p-STAT3 in human peripheral blood mononuclear cells. Tyk2-IN-25 is applicable to research related to multiple diseases such as immune and inflammatory diseases, and neurological diseases .
loading...
    loading...
Cat. No.: HY-109854AR
CAS No.: 100324-81-0
Synonyms: (R)-Lisophylline (Standard)
(R)-Lisofylline (Standard) is the analytical standard of (R)-Lisofylline (HY-109854A). This product is intended for research and analytical applications. (R)-Lisofylline ((R)-Lisophylline) is a (R)-enantiomer of the metabolite of Pentoxifylline with anti-inflammatory properties. (R)-Lisofylline is a lysophosphatidic acid acyltransferase inhibitor with an IC50 of 0.6 μM and interrupts IL-12 signaling-mediated STAT4 activation. (R)-Lisofylline has the potential for type 1 diabetes, autoimmune disorders research .
loading...
    loading...